Using AI to Predict Protein Shapes for Drug Discovery

This patent describes an AI-driven method for iteratively predicting protein 3D structures using a geometry neural network, then using those predictions to find and synthesize new drug molecules.

What it covers

The patent details a method for predicting the 3D shape (structure) of a protein, which is then used to identify and create new drug molecules, called ligands. The core process involves an iterative refinement loop (Claim 1). At each step, the system maintains a "current predicted structure" and generates an "alternative predicted structure." A "geometry neural network" then processes the protein's amino acid sequence and the alternative structure's parameters to produce a "geometry score" (Claim 1). This score estimates how similar the alternative structure is to the protein's actual shape. Based on this score, the system decides whether to update its current prediction. Once a sufficiently high-quality predicted structure is determined, the method evaluates how well various "candidate ligands" (potential drugs) might interact with this predicted protein shape. It selects candidates predicted to bind effectively and then proceeds to synthesize them (Claim 1).

What it doesn't cover

• —Does not cover protein structure prediction methods that do not use a geometry neural network to estimate similarity to an actual structure (Claim 1).
• —Does not cover methods for predicting protein structures that do not involve an iterative update process (Claim 1).
• —Does not cover protein structure prediction that isn't ultimately used for evaluating and selecting candidate drug ligands (Claim 1).
• —Does not cover methods that predict protein structures but do not include the step of synthesizing the selected ligands (Claim 1).
• —Does not cover protein structure prediction without considering the sequence of amino acid residues (Claim 1).

The clever bit

The core innovation is using a "geometry neural network" within an iterative refinement loop to estimate how similar a *predicted* protein structure is to its *actual* structure. This "geometry score" guides the system to improve its predictions, effectively learning to evaluate the quality of its own generated structures.

Why it matters

Accurately predicting a protein's 3D shape is a fundamental challenge in biology and crucial for designing new medicines. This patent describes an AI-driven approach to tackle this problem, which can significantly speed up drug discovery by computationally screening potential drug candidates against predicted protein targets before costly lab experiments.

Real-world examples

• 1.AlphaFold (DeepMind)
• 2.RoseTTAFold (University of Washington)
• 3.Computational drug discovery platforms
• 4.AI-driven pharmaceutical research